Anzeige
Mehr »
Login
Dienstag, 21.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0LFDN | ISIN: US01748X1028 | Ticker-Symbol: AGH
Tradegate
20.01.25
20:10 Uhr
99,50 Euro
-0,50
-0,50 %
1-Jahres-Chart
ALLEGIANT TRAVEL COMPANY Chart 1 Jahr
5-Tage-Chart
ALLEGIANT TRAVEL COMPANY 5-Tage-Chart
RealtimeGeldBriefZeit
99,50100,0008:29
99,50100,0008:22
PR Newswire
78 Leser
Artikel bewerten:
(0)

Allegiant Travel Company: Allegiant Reports November 2024 Traffic

Finanznachrichten News

LAS VEGAS, Dec. 12, 2024 /PRNewswire/ -- Allegiant Travel Company (NASDAQ: ALGT) today reported preliminary passenger traffic results for November 2024.

"Booking trends following the election continue to outpace our initial expectations," stated Drew Wells, Chief Commercial Officer of Allegiant Travel Company. "Demand recovery to hurricane-impacted destinations has been faster than expected, with demand to most impacted regions returning to normal. Additionally, close-in holiday demand during November exceeded our expectations with TRASM performing on par with the prior year during the week of Thanksgiving. December capacity is expected to be up 17 percent year-over-year, and we are encouraged by the strength in bookings for the December holiday period, which are outpacing our initial expectations. Based on recent booking trends, we now expect fourth quarter TRASM to be down approximately 1.5 percent year-over-year on capacity growth of 1.8 percent for the quarter, versus our initial TRASM expectation of down 4.5 percent year-over-year."

"We took delivery of two incremental 737-MAX aircraft in November," stated Robert Neal, Chief Financial Officer of Allegiant Travel Company. "We expect to end the year with four MAX aircraft in service, as compared with our initial expectation of one, bringing our total fleet count at year end to 125. With heightened confidence in 737 deliveries, we opportunistically executed a transaction during the fourth quarter to sell underutilized CFM engines, resulting in a $15 million gain. Considering these gains, we now expect fourth quarter CASM, excluding fuel and special charges, to be down 3.5 percent, year-over-year. Updated fourth quarter guidance is included in the table below."

Updated Fourth Quarter Guidance - Subject to Revision1


4Q24 - Updated

4Q24 - Prior

System ASMs - year-over-year change

~1.9%

~1.5%

Scheduled service ASMs - year-over-year change

~1.8%

~1.5%

Fuel cost per gallon

$2.50

$2.50

Airline-only operating margin

13.0% to 14.0%

6.0% to 8.0%

Airline-only earnings per share, excluding special charges1

$2.50 - $3.00

$0.50 - $1.50

Consolidated earnings per share, excluding special charges1

$1.75 - $2.25

$0.00 - $1.00

1 Certain forward-looking financial information in the above table is not presented in accordance with accounting principles generally accepted in the U.S. ("GAAP"). Non-GAAP financial figures may be useful to stakeholders, but should not be considered a substitute for GAAP figures. In reliance on the 'unreasonable efforts' exception in Item 10(e)(1)(i)(B) of SEC Regulation S-K, a reconciliation to the most comparable GAAP financial measure is not provided for airline-only earnings per share, excluding special charges, or consolidated earnings per share, excluding special charges. The Company is not able to reconcile these Non-GAAP financial figures without unreasonable effort because the special charge adjustments will not be known until the end of the indicated future period and any range of projected values would be too broad to be meaningful. As a result, this information would not be significant to investors.

Scheduled Service - Year Over Year Comparison


November 2024

November 2023

Change

Passengers

1,214,205

1,303,894

(6.9 %)

Revenue passenger miles (000)

1,108,281

1,178,002

(5.9 %)

Available seat miles (000)

1,381,831

1,405,369

(1.7 %)

Load factor

80.2 %

83.8 %

(3.6pts)

Departures

8,821

9,001

(2.0 %)

Average stage length (miles)

898

885

1.5 %

Total System* - Year Over Year Comparison


November 2024

November 2023

Change

Passengers

1,247,401

1,333,604

(6.5 %)

Available seat miles (000)

1,457,723

1,467,019

(0.6 %)

Departures

9,456

9,529

(0.8 %)

Average stage length (miles)

883

873

1.2 %

*Total system includes scheduled service and fixed fee contract. System revenue passenger miles and system load factor are not useful statistics as system available seat miles include both ASMs flown by fixed fee flying as well as non-revenue producing repositioning flights used for operational needs. Fixed fee flying is better measured through dollar contribution versus operational statistics.

Preliminary Financial Results


$ per gallon

November 2024 estimated average fuel cost per gallon - system

$2.52



Allegiant Travel Company

Las Vegas -based Allegiant (NASDAQ: ALGT) is an integrated travel company with an airline at its heart, focused on connecting customers with the people, places and experiences that matter most. Since 1999, Allegiant Air has linked travelers in small-to-medium cities to world-class vacation destinations with all-nonstop flights and industry-low average fares. Today, Allegiant's fleet serves communities across the nation, with base airfares less than half the cost of the average domestic roundtrip ticket. For more information, visit us at Allegiant.com. Media information, including photos, is available at gofly.us/iiFa303wrtF

ALGT/G

Note: This news release was accurate at the date of issuance. However, information contained in the release may have changed. If you plan to use the information contained herein for any purpose, verification of its continued accuracy is your responsibility.

For further information please visit the company's investor website: ir.allegiantair.com

Reference to the Company's website above does not constitute incorporation of any of the information thereon into this news release.

Allegiant Media Contact:


Investor Inquiries:

Sonya Padgett


Sherry Wilson

[email protected]


[email protected]

SOURCE Allegiant Travel Company

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.